Class II recall: ACCORD HEALTHCARE, INC.: Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-count bottles, Rx Onl
Accord Healthcare, Inc. has recalled Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), supplied in 1000-count bottles under NDC 16729-447-17. The product, manufactured by Intas Pharmaceuticals Limited in India, was recalled due to being subpotent, according to the recall notice. The action is classified as a Class II recall.<br>
Most relevant for: Children requiring levothyroxine replacement therapy who may have received subpotent doses from affected medication batches
Read the original at FDA Drug Enforcement ReportsSummary written by an AI model from the source text and dated by the source's publication date. Check the original before acting on it. How MedFollow selects and summarizes updates.
Informational only. Not medical advice. Not a substitute for clinical judgment. Always consult current guidelines and your own clinical judgment.
Specialties
More family medicine updates
- Long-Acting Injectable HIV Therapy Noninferior for Adherence ChallengesOct 15, 2026
- 8-week sofosbuvir-velpatasvir regimen non-inferior to 12 weeks for HCVSep 30, 2026
- Lean MASLD shows milder histology but similar mortality outcomesSep 30, 2026
- Oral GLP-1 orforglipron shows cardiovascular non-inferiority to insulin glargineSep 30, 2026
- Retatrutide produces substantial weight loss in phase 3 diabetes trialSep 29, 2026